Tra­con to seek ‘strate­gic’ op­tions; Ovid to lay off 17 work­ers

Plus, news about Mer­ck, Ori­on, Tonix, Freeflow and Y-mAbs Ther­a­peu­tics:

Tra­con Phar­ma­ceu­ti­cals seeks ‘strate­gic al­ter­na­tives’ af­ter PD-L1 fails Ph2 tri­al: In an 82-per­son sar­co­ma study …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER